Avalo Therapeutics Inc (AVTX)
10.85
+1.21
(+12.55%)
USD |
NASDAQ |
May 20, 16:00
10.85
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Cash from Investing (TTM): 0.356M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 0.356M |
December 31, 2023 | -0.133M |
September 30, 2023 | -0.133M |
June 30, 2023 | -0.172M |
March 31, 2023 | -0.228M |
December 31, 2022 | -0.095M |
September 30, 2022 | -0.106M |
June 30, 2022 | -0.148M |
March 31, 2022 | -0.092M |
December 31, 2021 | -0.113M |
September 30, 2021 | -0.493M |
June 30, 2021 | -0.475M |
March 31, 2021 | 12.36M |
December 31, 2020 | 11.13M |
September 30, 2020 | 11.34M |
June 30, 2020 | 11.40M |
Date | Value |
---|---|
March 31, 2020 | -1.528M |
December 31, 2019 | -0.443M |
September 30, 2019 | -0.7614M |
June 30, 2019 | 0.6345M |
March 31, 2019 | 0.7187M |
December 31, 2018 | 0.8655M |
September 30, 2018 | -17.54M |
June 30, 2018 | -18.94M |
March 31, 2018 | -18.93M |
December 31, 2017 | -18.91M |
September 30, 2017 | -0.0172M |
June 30, 2017 | -0.0175M |
March 31, 2017 | -0.0278M |
December 31, 2016 | -0.0349M |
September 30, 2016 | -0.0256M |
June 30, 2016 | -0.0391M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.528M
Minimum
Mar 2020
12.36M
Maximum
Mar 2021
2.115M
Average
-0.123M
Median
Cash from Investing (TTM) Benchmarks
Imunon Inc | 12.97M |
iBio Inc | 1.044M |
Kodiak Sciences Inc | 75.65M |
Petros Pharmaceuticals Inc | -- |
Ocugen Inc | -2.716M |